Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

INAB stock hub

IN8bio, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

INABis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

15.6M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

INAB

In the news

Latest news · INAB

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-103.6

P25 -105.6P50 -46.5P75 -3.1

ROIC-56.2

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All INAB market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

180

Groups with data

Currency

USD

Showing 180 of 180 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001740279
Company name	IN8bio, Inc.
Country	United States
Country code	US
Cusip	45674E208
Employees	17
Employees Change	-1%
Employees Change Percent	-5.56
Enterprise value	$-4M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2021-07-30
Isin	US45674E2081
Last refreshed	2026-05-10
Market cap	$15.6M
Market cap category	Nano-Cap
Price	$1.6
Price currency	USD
Sector	Healthcare
Sic	2836
Symbol	INAB
Website	https://in8bio.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-121.99%
FCF yield	-93.49%
P/B ratio	0.68x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-19M
Net Income Growth Quarters	7%
Net Income Growth Years	1%
Profit Per Employee	$-1.1M
ROA	-52.75
Roa5y	-49.51
ROCE	-80.75
ROE	-103.6
Roe5y	-103.7
ROIC	-56.22

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-67.7%
Cagr3y	-71.63%
EPS Growth Quarters	13
EPS Growth Years	5
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$26.3M
Cash	$21.9M
Current Assets	$22.7M
Current Liabilities	$2.2M
Debt	$2.4M
Debt Equity	$0.1
Equity	$22.8M
Liabilities	$3.5M
Long Term Assets	$3.6M
Long Term Liabilities	$1.3M
Net Cash	$19.6M
Net Cash By Market Cap	$126
Net Cash Growth	157.18%
Net Debt Equity	$-0.86
Tangible Book Value	$22.8M
Tangible Book Value Per Share	$2.31
WACC	4.07

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	10.5
Net Working Capital	$-409,000
Quick ratio	10.17
Working Capital	$20.5M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-315.73%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-67.68%
200-day SMA	1.92
3Y total return	-97.72%
50-day SMA	1.59
50-day SMA vs 200-day SMA	50under200
All Time High	309.6
All Time High Change	-99.48%
All Time High Date	2021-08-11
All Time Low	1.17
All Time Low Change	36.32%
All Time Low Date	2025-12-19
ATR	0.11
Beta	0.08
Beta1y	1.25
Beta2y	1.73
Ch YTD	-31.84
High	1.66
High52	5.61
High52 Date	2025-05-29
High52ch	-71.57%
Low	1.55
Low52	1.17
Low52 Date	2025-12-19
Low52ch	36.33%
Ma50ch	0.06%
Price vs 200-day SMA	-17.06%
RSI	53.25
RSI Monthly	26.09
RSI Weekly	42.18
Sharpe ratio	-0.88x
Sortino ratio	-1.22
Total Return	-315.73%
Tr YTD	-31.84
Tr1m	11.54%
Tr1w	6.33%
Tr3m	-19.85%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	1
Analyst Count Top	1
Analyst Price Target Top	$6
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.67
Operating Income	$-19.5M
Price target	$6
Price Target Change	$276
Price Target Change Top	$276

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	7,029,350%
Float Percent	71.39%
Net Borrowing	-575,000
Shares Insiders	11.53%
Shares Institutions	25.43%
Shares Out	9,847,089
Shares Qo Q	174.13%
Shares Yo Y	315.73%
Short Float	4.98%
Short Ratio	4.29
Short Shares	3.56

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-17.3M
Average Volume	64,847.3x
Bv Per Share	2.31
CAPEX	$-9,000
Ch1m	11.54
Ch1w	6.33
Ch1y	-67.68
Ch3m	-19.85
Ch3y	-97.72
Ch6m	2.9
Change	-0.31%
Change From Open	-3.92
Close	1.6
Days Gap	3.75
Depreciation Amortization	1,628,000
Dollar Volume	67,811.4
Earnings Date	2026-05-07
Earnings Time	amc
EBIT	$-19.5M
EBITDA	$-17.8M
EPS	$-2.21
F Score	2
FCF	$-14.5M
FCF EV Yield	361.07x
FCF Per Share	$-1.48
Financing CF	24,550,000
Fiscal Year End	December
Founded	2,016
Investing CF	-9,000
Ipr	-84.05
Iprfo	-99.47
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-07
Last Report Date	2026-03-31
Last Split Date	2025-06-06
Last Split Type	Reverse
Last10k Filing Date	2026-03-12
Ma150	1.83
Ma150ch	-13.03%
Ma20	1.5
Ma20ch	6.4%
Net CF	10,004,000
Next Earnings Date	2026-08-06
Open	1.66
Optionable	No
Position In Range	39.81
Post Close	1.6
Postmarket Change Percent	-0.94
Postmarket Price	$1.58
Ppne	3,254,000
Price Date	2026-05-08
Ptbv Ratio	0.68
Relative Volume	0.66x
Share Based Comp	2,759,000
Tr6m	2.9%
Us State	New York
Volume	42,515

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does INAB pay a dividend?

Capital-return profile for this ticker.

Performance

INAB stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns INAB?

Insider, institutional, and short-interest positioning.

Institutional ownership

+25.4%

Float: +71.4% of shares outstanding

Insider ownership

+11.5%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

INAB momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

53.2

Neutral momentum band

Price vs 200-day MA

-17.1%

50/200-day relationship not available

Beta (5Y)

0.08

Less volatile than the market

Sharpe ratio

-0.88

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About INAB

Hub-level FAQ points readers to the deeper analysis pages.

What is the current INAB stock rating?

IN8bio, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full INAB analysis?

The full report lives at /stocks/INAB/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for INAB?

The latest report frames INAB around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the INAB page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.